Progressive Familial Intrahepatic Cholestasis Models

Some autosomal recessive mutations in the bile acid membrane transporters affecting hepatocytes lead to progressive familial intrahepatic cholestasis (PFIC), a group of diseases characterized by cholestasis, pruritus, and often an eventual requirement for liver transplantation. The estimated incidence of PFIC ranges from 1 in 50,000 to 1 in 100,000 live births.


● Genetically Engineered PFIC Mouse Models

Strain No.
Strain Name Strain Type Description
T007421 Abcb4-KO Knockout Abcb4-KO homozygous mice show impaired liver function and development of liver fibrosis from 8 weeks old
T012640 Nr1h4-KO Knockout Nr1h4-KO homozygous mice show impaired liver function and elevated serum TBA level. Lipid metabolism in this model is also impaired, as indicated by reduced serum TG and increased serum cholesterol levels